References
- Eder, W., Ege, M.J., von Mutius, E. The asthma epidemic. N. Engl. J. Med. 2006, 355, 2226–35.
- Robinson, D.S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A.M., Corrigan, C., Durham, S.R., Kay, A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992, 326, 298–304.
- Walker, C., Kaegi, M.K., Braun, P., Blaser, K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 1991, 88, 935–42.
- Bochner, B.S., Undem, B.J., Lichtenstein, L.M. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 1994, 12, 295–335.
- Cohn, L., Elias, J.A., Chupp, G.L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004, 22, 789–815.
- Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., Donaldson, D.D. Interleukin-13: central mediator of allergic asthma. Science 1998, 282, 2258–61.
- Grünig, G., Warnock, M., Wakil, A.E., Venkayya, R., Brombacher,F., Rennick, D.M., Sheppard, D., Mohrs, M., Donaldson, D.D., Locksley, R.M., Corry, D.B. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282, 2261–3.
- Wills-Karp, M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004, 202, 175–90.
- Steinke, J.W., Borish, L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2001, 2, 66–70.
- Dabbagh, K., Takeyama, K., Lee, H.M., Ueki, I.F., Lausier, J.A., Nadel, J.A. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 1999, 162, 6233–7.
- Bryborn, M., Adner, M., Cardell, L.O. Interleukin-4 increases murine airway response to kinins, via up-regulation of bradykinin B1-receptors and altered signalling along mitogen-activated protein kinase pathways. Clin. Exp. Allergy 2004, 34, 1291–8.
- Callard, R.E., Matthews, D.J., Hibbert, L. IL-4 and IL-13 receptors: are they one and the same? Immunol. Today 1996, 17, 108–10.
- Chatila, T.A. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends. Mol. Med. 2004, 10, 493–499.
- Hebenstreit, D., Wirnsberger, G., Horejs-Hoeck, J., Duschl, A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev. 2006, 17, 173–88.
- Kuperman, D.A., Schleimer, R.P. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr. Mol. Med. 2008, 8, 384–92.
- Akimoto, T., Numata, F., Tamura, M., Takata, Y., Higashida, N., Takashi, T., Takeda, K., Akira, S. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 1998, 187, 1537–42.
- Kuperman, D., Schofield, B., Wills-Karp, M., Grusby, M.J. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 1998, 187, 939–48.
- McCusker, C.T., Wang, Y., Shan, J., Kinyanjui, M.W., Villeneuve,A., Michael, H., Fixman, E.D. Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J. Immunol. 2007, 179, 2556–64.
- Quarcoo, D., Weixler, S., Groneberg, D., Joachim, R., Ahrens, B., Wagner, A.H., Hecker, M., Hamelmann, E. Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J. Allergy Clin. Immunol. 2004, 114, 288–95.
- Simeone-Penney, M.C., Severgnini, M., Tu, P., Homer, R.J., Mariani, T.J., Cohn, L., Simon, A.R. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J. Immunol. 2007, 178, 6191–9.
- Chiba, Y., Ueno, A., Shinozaki, K., Takeyama, H., Nakazawa, S., Sakai, H., Misawa, M. Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice. Respir. Res. 2005, 6, 4.
- Chiba, Y., Kurotani, R., Kusakabe, T., Miura, T., Link, B.W., Misawa, M., Kimura, S. Uteroglobin-related protein 1 expression suppresses allergic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2006, 173, 958–64.
- Chiba, Y., Nakazawa, S., Todoroki, M., Shinozaki, K., Sakai, H., Misawa, M. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. Am. J. Respir. Cell Mol. Biol. 2009, 40, 159–67.
- Chiba, Y., Todoroki, M., Nishida, Y., Tanabe, M., Misawa, M. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. Am. J. Respir. Cell Mol. Biol. 2009, 41, 516–24.
- Chiba, Y., Onoda, S., Hattori, Y., Maitani, Y., Sakai, H., Misawa,M. Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma. Lung 2009, 187, 179–85.
- Gernez, Y., Tirouvanziam, R., Nguyen, K.D., Herzenberg, L.A., Krensky, A.M., Nadeau, K.C. Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids. J. Allergy Clin. Immunol. 2007, 120, 1441–8.
- Phipps, S., Benyahia, F., Ou, T.T., Barkans, J., Robinson, D.S., Kay, A.B. Acute allergen-induced airway remodeling in atopic asthma. Am. J. Respir. Cell Mol. Biol. 2004, 31, 626–32.
- Ohga, K., Kuromitsu, S., Takezawa, R., Numazaki, M., Ishikawa, J., Nagashima, S., Shimizu, Y. YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models. Eur. J. Pharmacol. 2008, 590, 409–16.
- Darcan-Nicolaisen, Y., Meinicke, H., Fels, G., Hegend, O., Haberland, A., Kühl, A., Loddenkemper, C., Witzenrath, M., Kube, S., Henke, W., Hamelmann, E. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice. J. Immunol. 2009, 182, 7501–8.
- Sampath, D., Castro, M., Look, D.C., Holtzman, M.J. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J. Clin. Invest. 1999, 103, 1353–61.
- Hattori, H., Rosas, L.E., Okano, M., Durbin, J.E., Nishizaki, K., Satoskar, A.R. STAT1 is involved in the pathogenesis of murine allergic rhinitis. Am. J. Rhinol. 2007, 21, 241–7.
- Darnell, J.E. Jr. STATs and gene regulation. Science 1997, 277, 1630–5.
- Wang, I.M., Lin, H., Goldman, S.J., Kobayashi, M. STAT-1 is activated by IL-4 and IL-13 in multiple cell types. Mol. Immunol. 2004, 41, 873–84.
- Gao, H., Ward, P.A. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin. Ther. Targets 2007, 11, 869–80.
- Paul, B., Mishra, V., Chaudhury, B., Awasthi, A., Das, A.B., Saxena, U., Saxena, A., Chauhan, L.K., Kumar, P., Raisuddin, S. Status of Stat3 in an ovalbumin-induced mouse model of asthma: analysis of the role of Socs3 and IL-6. Int. Arch. Allergy Immunol. 2009, 148, 99–108.